Jan 26
12:00 pm | Virtual

Who is missing? Underrepresented communities in trauma research

Presented by Dr. Barbara Haas, MD, PhD, FRCSC Assistant Professor, Department of Surgery, University of Toronto Learning objectives To review the relationship between sex and trauma outcomes To review the link between age and trauma outcomes To review the link between marginalization and trauma

Dec 15
12:00 pm | Virtual

Big data applications in transfusion medicine: Size matters

Presented by Dr. Ruchika Goel, MD, MPH Associate Professor of Internal Medicine and Pediatrics Associate Vice Chair of Research, Department of Internal Medicine, SIU School of Medicine Div. of Hematology/Oncology, Simmons Cancer Institute at SIU SOM Learning objectives To provide an overview of Big

Dec 15
4:00 pm | Webinar

International OTDT Webinar

International OTDT Webinar Viral Ecology: anticipated trends / threats to donation-transplant systems and health care systems capacity. Canadian Blood Services and the International Society for Donation and Organ Procurement will be co-hosting a quarterly international call. The first webinar will

Dec 6
11:00 am | Virtual

Best of the Transfusion Evidence Library 2022

This webinar, presented as part of ISBT's Live Journal Club, will discuss the December Evidence Round-Up which focuses on a selection of top 10 papers from 2022 covering a range of transfusion related topics from the Transfusion Evidence Library. The webinar will take place at 11:00am Central

Canadian Blood Services Research Ethics Board seeks new Volunteer Researcher Member

Guiding the research that informs the future of transfusion, cellular therapy and transplantation By engaging an extended network of partners, Canadian Blood Services’ research sparks discovery, informs the development of new products and processes, contributes to the sharing of knowledge, and guides best practices for the care of patients and donors connected to Canada’s lifeline. A multidisciplinary Research Ethics Board (REB) reviews all research applications involving human participants that are intended to be conducted by, or on behalf of, Canadian Blood Services. This includes research
November 29, 2022

Dec 1
1:00 pm | Webinar

Can-SOLVE CKD

Webinar: Can-SOLVE CKD Learning Tree Can-SOLVE CKD will host a webinar on December 1 at 10:00 a.m. PST / 1:00 p.m. EST to introduce the five branches of the Learning Tree. This suite of training programs aims to help patients and researchers enhance their skills and knowledge in patient-oriented

May 10
2:00 pm | Virtual

Immunohematology boot camp: MNS system

The MNS blood group system, which is comprised of 50 antigens, is a complex and clinically significant system as it is associated with hemolytic transfusion reactions (HTRs) and hemolytic disease of the fetus and newborn (HDFN). The focus of this program is to provide a review (via lecture) of the

Feb 8
2:00 pm | Virtual

Immunohematology boot camp: HLA antibodies - The platelet refractory patient

This program is designed to define platelet refractoriness, detail common laboratory values associated with refractoriness, and recognize these in the context of a patient case. In addition, distinguish platelet refractoriness from other common platelet issues. This program will be a lecture-based

Nov 30
1:00 pm | Virtual/Vancouver

Seminar series: Banking with precision - The future of genomics in transfusion

Part of the CBR seminar series, this lecture will review the genomic basis of blood groups, describe the application of genomic technologies to elucidate the blood phenotype diversity in Canadian blood donors and patients, and discuss the future applications of genomics in blood product

Nov 30
12:00 pm | Virtual

De-implementation of an exemplar low-value practice: Albumin fluid resuscitation in critical care

This webinar is part of the De/Implement series by Choosing Wisely Canada's Implementation Research Network (CWC-IRN). Dr. Daniel Niven will share results and lessons learned from a multifaceted quality improvement intervention to reduce low-value albumin use among adults admitted to intensive care